Home > Boards > US Listed > Biotechs >

Aclaris Therapeutics, Inc. (ACRS)

Add ACRS Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 7/31/2018 5:57:22 PM - Followers: 6 - Board type: Free - Posts Today: 0

Aclaris Therapeutics, Inc. 101 Lindenwood Drive Suite 400 Malvern, PA 19355 United States 484-324-7933 http://www.aclaristx.com Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ACRS News: Amended Current Report Filing (8-k/a) 01/18/2019 04:36:21 PM
ACRS News: Statement of Changes in Beneficial Ownership (4) 01/18/2019 02:57:10 PM
ACRS News: Statement of Changes in Beneficial Ownership (4) 01/02/2019 05:35:05 PM
ACRS News: Aclaris Therapeutics to Attend Upcoming Investor Conferences 01/02/2019 07:00:00 AM
ACRS News: Statement of Changes in Beneficial Ownership (4) 12/21/2018 07:36:21 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#3   This stock going to $30 after FDA approval! Engle1488 07/31/18 05:57:22 PM
#2   You proved right about this stock since your HappyLibrarian 01/24/18 09:52:56 AM
#1   ACRS bullish 22.07 stocktrademan 09/06/16 11:44:47 AM